Table 1 Baseline characteristics according to the clinical functional outcome
|  | Good Outcome (N = 264) | Poor Outcome (N = 33) | P |
|---|---|---|---|
Demographics | |||
 Age, y, mean ± SD | 34.2 ± 11.6 | 44.4 ± 16.3 | < 0.001 |
 Female, n (%) | 155(58.7) | 23(69.7) | 0.225 |
Possible Risk factors, n (%) | |||
 Infections | 66(25.9) | 8(24.2) | 0.839 |
 Pregnancy/postpartum | 66(25.0) | 7(21.2) | 0.634 |
Clinical symptoms, n (%) | |||
 Intracranial hypertension | 175(66.3) | 22(66.7) | 0.965 |
 Seizure | 74(28.0) | 12(36.4) | 0.320 |
 Coma | 67(25.4) | 23(69.7) | < 0.001 |
 Mental status disturbance | 13(4.9) | 4(12.1) | 0.200 |
 Focal neurological deficitsa | 86(32.6) | 18(54.5) | 0.013 |
Involved sinuses, n (%) | |||
 Transverse sinuses | 99(37.5) | 12(36.4) | 0.899 |
 Sigmoid sinuses | 87(33.0) | 9(27.3) | 0.511 |
 Superior sagittal sinus | 106(40.2) | 13(39.4) | 0.933 |
 Straight sinus | 16(6.1) | 6(18.2) | 0.012 |
 Inferior sagittal sinus | 18(6.8) | 3(9.1) | 0.904 |
 Deep CVT | 9(3.4) | 2(6.1) | 0.786 |
Parenchymal lesion, n (%) | |||
 Ischemic Infarction | 40(15.2) | 8(24.2) | 0.181 |
 Intracerebral hemorrhage | 54(20.5) | 15(45.5) | 0.001 |
Laboratory Examinations | |||
 White Blood Cell, 109/L | 9.6 ± 5.0 | 10.9 ± 5.5 | 0.165 |
 Lymphocyte count, ×109/L | 1.6 ± 0.8 | 1.1 ± 0.5 | < 0.001 |
 Serum albumin, g/dL | 40.5 ± 5.0 | 37.4 ± 5.0 | 0.001 |
 PNI | 49.3 ± 6.3 | 42.3 ± 6.1 | < 0.001 |
Hospital treatment, n (%) | |||
 Anticoagulation | 262(99.2) | 31(93.9) | 0.062 |
 Endovascular Therapies | 125(47.3) | 19(57.6) | 0.268 |